Pennant Investors, LP

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Pennant Investors, LP reported 42 stock positions worth $361.7 million. Its top holding was Amazon.com (AMZN) at 14.8% of the portfolio, followed by Transdigm (TDG, 14.3%) and Microsoft (MSFT, 13.0%). Compared with Q4 2023, it opened 2 new positions, sold out of 1, added to 1 and reduced 3. The biggest buy was a new position in Enovis (ENOV) and the biggest sale Alphabet Class A (GOOGL, shares −47%).

Most Recent 13F
Q2 2026
Location
Summit, NJ
CIK
0001759176
Portfolio Value
$361.7M (Q1 2024)
SEC Filing
0000919574-24-003124 ↗ filed May 15, 2024

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $361.7M $361.7M Q1 2024 Q2 2024: $366.2M Q2 2024 Q3 2024: $336.0M Q3 2024 Q4 2024: $336.7M Q4 2024 Q1 2025: $332.4M Q1 2025 Q2 2025: $334.3M Q2 2025 Q3 2025: $371.7M Q3 2025 Q4 2025: $410.6M Q4 2025 Q1 2026: $361.0M Q1 2026 Q2 2026: $334.9M Q2 2026

Holdings 42 stocks · $361.7M
AMZN Amazon.com Inc. 14.76% 296,000 $53.4M Reduce -14.9%
TDG Transdigm Group Inc. 14.30% 42,000 $51.7M No change
MSFT Microsoft Corp. 13.03% 112,000 $47.1M Reduce -13.2%
MU Micron Technology Inc. 9.97% 306,000 $36.1M No change
AR Antero Resources Corp. 9.08% 1,133,000 $32.9M Add +24.1%
ECHO Echostar Corp. Class A 8.48% 2,153,209 $30.7M No change
GOOGL Alphabet Inc. Class A 8.30% 199,000 $30.0M Reduce -46.9%
ENOV Enovis Corp. 6.91% 400,000 $25.0M New
ODP The Odp Corp. filed as THE ODP CORP 5.87% 400,000 $21.2M No change
PRM Perimeter Solutions SA 4.72% 2,300,000 $17.1M No change
FIBROGEN INC 0.50% 768,400 $1.8M No change
ARQT Arcutis Biotherapeutics Inc. 0.47% 170,900 $1.7M No change
ALT Altimmune Inc. 0.31% 109,800 $1.1M No change
FATE Fate Therapeutics Inc. 0.30% 146,100 $1.1M No change
NRIX Nurix Therapeutics Inc. 0.23% 56,800 $835K No change
MGNX Macrogenics Inc. 0.18% 43,800 $645K No change
IGMS Igm Biosciences Inc. 0.17% 64,900 $626K No change
ENTA Enanta Pharmaceuticals Inc. 0.17% 35,100 $613K No change
ALLO Allogene Therapeutics Inc. 0.16% 128,400 $574K No change
ETNB 89BIO Inc. 0.14% 44,500 $518K No change
ZNTL Zentalis Pharmaceuticals Inc. 0.14% 32,400 $511K No change
RCUS Arcus Biosciences Inc. 0.12% 23,700 $447K No change
ARCT Arcturus Therapeutics Holdin 0.12% 13,100 $442K No change
AGIO Agios Pharmaceuticals Inc. 0.12% 15,100 $442K No change
TRAVERE THERAPEUTICS INC (TVTX 2.5 09/15/25) 0.12% 55,800 $430K New
GETR Getaround Inc. 0.11% 1,348,153 $414K No change
ZYME Zymeworks Inc. 0.11% 38,700 $407K No change
CHRS Coherus Oncology Inc. 0.11% 168,100 $402K No change
CMPX Compass Therapeutics Inc. 0.11% 199,000 $394K No change
RLAY Relay Therapeutics Inc. 0.10% 42,400 $352K No change
ERAS Erasca Inc. 0.09% 166,200 $342K No change
SAGE Sage Therapeutics Inc. 0.09% 17,500 $328K No change
NVAX Novavax Inc. 0.08% 60,300 $288K No change
AGEN Agenus Inc. 0.08% 469,600 $272K No change
QURE Uniqure NV 0.07% 48,500 $252K No change
REPL Replimune Group Inc. 0.07% 30,500 $249K No change
BTAIQ Bioxcel Therapeutics Inc. 0.07% 83,900 $237K No change
ALLK Allakos LLC 0.06% 186,100 $234K No change
MCRB Seres Therapeutics Inc. 0.06% 292,300 $226K No change
ALLOVIR INC 0.04% 215,700 $163K No change
MIMOQ Airspan Networks Holdings Inc. 0.03% 1,047,473 $118K No change
BLUEBIRD BIO INC 0.03% 87,400 $112K No change

Options reported separately and not counted above: AAPL puts ($27.4M), AR calls ($14.5M).

Other holdings (1): bonds, preferreds, convertibles and warrants · $16K (not counted above)
SecurityClassShares / PrincipalValueChange
GRABW Grab Holdings Ltd.-CW 26 *W EXP 99/99/999 80,000$16KNo change

Total filed on the 13F, all lines: $361.7M.

Portfolio Sells Q4 2023 → Q1 2024
GOOGL Alphabet Inc. Class A Reduce -46.9% 8.30% −7.79
MSFT Microsoft Corp. Reduce -13.2% 13.03% −1.88
AMZN Amazon.com Inc. Reduce -14.9% 14.76% −1.49
TVTX Travere Therapeutics Inc. Sold out 0.00% −0.15

Portfolio Buys Q4 2023 → Q1 2024
ENOV Enovis Corp. New 6.91% +6.91
AR Antero Resources Corp. Add +24.1% 9.08% +2.72
TRAVERE THERAPEUTICS INC (TVTX 2.5 09/15/25) New 0.12% +0.12

Options Activity Q4 2023 → Q1 2024
AAPL Apple Inc. put Reduce -74.6% 160,000 $27.4M

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 15$334.9MSOLS, AMZN, MSFT, ECHO, PRM
Q1 2026 16$361.0MSOLS, ECHO, MSFT, VRT, AMZN
Q4 2025 15$410.6MECHO, MSFT, SOLS, PRM, GOOGL
Q3 2025 14$371.7MECHO, MSFT, CORZ, PRM, AMZN
Q2 2025 15$334.3MMSFT, ECHO, TDG, PRM, AR
Q1 2025 15$332.4MECHO, AMZN, TDG, AR, MSFT
Q4 2024 14$336.7MECHO, AMZN, AR, PRM, GOOGL
Q3 2024 14$336.0MECHO, PRM, MU, AMZN, AR
Q2 2024 44$366.2MMU, AMZN, TDG, ECHO, MSFT
Q1 2024 42$361.7MAMZN, TDG, MSFT, MU, AR